- QMRO Home
- Blizard Institute
- Centre for Neuroscience, Surgery and Trauma
- A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study
Browse
Administrators only